Indication · Neurology & Neurosurgery
ADHD
Last checked: Nov 19, 2026Source: FDA, ClinicalTrials.gov
Devices
18
Cleared or approved since 2000
PMA and De Novo
3
Higher-risk or first-of-kind devices
Breakthrough devices
1
Authorized through June 30, 2026
Recruiting device trials
32
174 device trials in all
Breakthrough-designated devices
- Ceribell Delirium Monitor SystemCeribell, Inc. · 2025
Devices
18 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- EndeavorRx
Akili Interactive Labs, Inc. · De Novo · Digital Therapeutic Software For Attention Deficit Hyperactivity Disorder · newest 2023 · 2 decisions
- Monarch eTNS System
Neurosigma, Inc. · De Novo · Transcutaneous Nerve Stimulator For Adhd · newest 2019
- Neba System
Lexicor Medical Technology, LLC · De Novo · Neuropsychiatric Interpretative Electroencephalograph Assessment Aid · newest 2013
- Test of Variables of Attention (T.O.V.A.)
The Tova Company · 510(k) · Recorder, Attention Task Performance · newest 2018 · 2 decisions
- Ceribell Delirium Monitor System
Ceribell, Inc. · 510(k) · Neuropsychiatric Interpretative Electroencephalograph Assessment Aid · newest 2025
- Prismira
Lumos Labs, Inc. · 510(k) · Digital Therapeutic Software For Attention Deficit Hyperactivity Disorder · newest 2025
- Addnox (BPSPM1)
Nu Eyne Co., Ltd. · 510(k) · Transcutaneous Nerve Stimulator For Adhd · newest 2025
- BT-1000
Bistos Co., Ltd. · 510(k) · Transcutaneous Nerve Stimulator For Adhd · newest 2024
- EndeavorOTC
Akili Interactive Labs, Inc. · 510(k) · Digital Therapeutic Software For Attention Deficit Hyperactivity Disorder · newest 2024
- Generation 2.0 Monarch external Trigeminal Nerve Stimulation (eTNS) System®
Neurosigma, Inc. · 510(k) · Transcutaneous Nerve Stimulator For Adhd · newest 2024
- Smile
Nu Eyne Co., Ltd. · 510(k) · Transcutaneous Nerve Stimulator For Adhd · newest 2023
- DeltaScan Monitor
Prolira B.V. · 510(k) · Neuropsychiatric Interpretative Electroencephalograph Assessment Aid · newest 2023
- QbCheck
Qbtech AB · 510(k) · Recorder, Attention Task Performance · newest 2016
- Dana
Anthrotronix, Inc. · 510(k) · Recorder, Attention Task Performance · newest 2014
- Qb Test
Qbtech AB · 510(k) · Recorder, Attention Task Performance · newest 2014
- Qbtes
Qbtech AB · 510(k) · Recorder, Attention Task Performance · newest 2012
- Qbtest
Qbtech AB · 510(k) · Recorder, Attention Task Performance · newest 2004
- Optax System
Optax Systems, Inc. · 510(k) · Recorder, Attention Task Performance · newest 2002
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- AI-assisted Home-based Intervention for ADHD ChildrenPivotal-lookingRecruiting
National Taiwan University HospitalAcademic, hospital or other
NCT07922018 · 120 participants (planned) · Start Aug 1, 2026 · Primary completion Jul 31, 2027
Device: Generative artificial intelligence assisted diary platform home-based intervention · For: ADHD - Attention Deficit Disorder With Hyperactivity; ADHD - Combined Type; ADHD - Inattentive Type
Sites: Hsinchu, Taiwan
The Third Affiliated Hospital of Beijing University of Chinese MedicineAcademic, hospital or other
NCT06860763 · 120 participants (planned) · Start Oct 15, 2024 · Primary completion Dec 15, 2026
Device: Acupuncture · For: Acupuncture; ADHD - Attention Deficit Disorder With Hyperactivity; Children and 3 more
Sites: Beijing, China
University of California, Los AngelesAcademic, hospital or other
NCT06847165 · 30 participants (planned) · Start Apr 26, 2025 · Primary completion Dec 29, 2026
Device: Trigeminal Nerve Stimulation (TNS) · For: Fetal Alcohol Spectrum Disorders; Attention Deficit Hyperactivity Disorder
Sites: Los Angeles, California
- External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated SymptomsRecruiting
University of California, San FranciscoAcademic, hospital or other
NCT07214545 · 60 participants (planned) · Start Oct 6, 2025 · Primary completion Sep 2027
Device: Trigeminal Nerve Stimulation; Sham Trigeminal Nerve Stimulation · For: Attention Deficit Disorder With Hyperactivity (ADHD); Autism Spectrum Disorder (ASD)
Sites: San Francisco, California
- Developing Virtual Reality Programs to Address Social Skills Deficits in Youth With ADHDNot yet recruiting
Indiana UniversityAcademic, hospital or other
NCT07882823 · 48 participants (planned) · Start Nov 1, 2026 · Primary completion May 31, 2027
Device: VIP Suite · For: Attention-Deficit/Hyperactivity Disorder (ADHD)
- Virtual Reality Attention ManagementRecruiting
University of California, DavisAcademic, hospital or other
NCT03221244 · 50 participants (planned) · Start Jun 2, 2016 · Primary completion Sep 2, 2027
Device: VR Treatment; VR Active Control · For: ADHD
Sites: Sacramento, California
VA Office of Research and DevelopmentFederal agency
NCT07442058 · 35 participants (planned) · Start Dec 1, 2026 · Primary completion Dec 1, 2027
Device: Intermittent Theta-Burst Stimulation; Sham Stimulation · For: Attention Deficit Disorder With Hyperactivity
Sites: Providence, Rhode Island
- Methodology of Super-Early Training of Developer Engineers and Leading Analysts With a Diagnosis of ADHD/ASD for Ensuring the Engineering Sovereignty of the State: Time Horizon: 2026-2038-2050Active, not recruiting
Pisareva Citadel Group LLCAcademic, hospital or other
NCT07845292 · 2 participants · Start Aug 1, 2026 · Primary completion Dec 31, 2026
Device: Voice of Sleep "MamaBee" training modules (Fairy Tales) · For: Attention Deficit Hyperactivity Disorder (ADHD)
Sites: NewYork, New York
Qbtech ABNot on our public-company list
NCT07329673 · 300 participants (planned) · Start Jan 1, 2026 · Primary completion Nov 2027
Device: Digital software application for cognitive performance and activity measurement (QbMobile, investigational device) · For: Bi-Polar Disorder; Autism Spectrum Disorder (ASD); Major Depression Disorders and 3 more
Sites: Miami, Florida
- Rapid Entrainment and Signal-guided Neuromodulation for Behavioral HealthPivotal-lookingActive, not recruiting
Tactical Mind Research Coalition, Inc.Academic, hospital or other
NCT07812987 · 240 participants (planned) · Start Aug 1, 2026 · Primary completion Jun 30, 2028
Device: Transcutaneous Auricular Vagus Nerve Stimulation; Audiovisual Entrainment and 2 more · For: Anxiety; PTSD; ADHD and 5 more
Sites: Tampa, Florida
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
Research
- Device studies on attention deficit hyperactivity disorder across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.